TP53 and lung carcinoma: To further understand the molecular mechanisms underlying the observed effect on lung cancer progression, we carried out transcriptomic analyses revealing that FIH deletion results in the dysregulation of several key pathways that control cell proliferation and survival, including the p53/p21 axis (53).